A Clinical Adverse Drug Reaction Prediction Model for Patients with Chagas Disease Treated with Benznidazole

Benznidazole (BZN) is the main trypanocidal drug used to treat Chagas disease, and the evidence supporting the benefits of BZN use during the chronic phase of the disease will favor its use in millions of individuals. However, more than 30% of patients treated with BZN may suffer adverse drug reacti...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Sperandio da Silva, Gilberto Marcelo, Mediano, Mauro Felippe Felix, Alvarenga Americano do Brasil, Pedro Emmanuel, da Costa Chambela, Mayara, da Silva, Joyce Almeida, de Sousa, Andrea Silvestre, Xavier, Sergio Salles, Rodrigues da Costa, Andrea, Magalhães Saraiva, Roberto, Hasslocher-Moreno, Alejandro Marcel
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2014
Assuntos:
Pharmacology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4249401/
https://ncbi.nlm.nih.gov/pubmed/25114135
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02842-14
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados